Your browser doesn't support javascript.
loading
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.
Goebeler, M; Bata-Csörgo, Z; De Simone, C; Didona, B; Remenyik, E; Reznichenko, N; Stoevesandt, J; Ward, E S; Parys, W; de Haard, H; Dupuy, P; Verheesen, P; Schmidt, E; Joly, P.
Afiliação
  • Goebeler M; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Bata-Csörgo Z; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
  • De Simone C; Department of Dermatology, Catholic University of the Sacred Heart, Policlinic A. Gemelli, Rome, Italy.
  • Didona B; Dermatopathic Institute of the Immaculate, Rome, Italy.
  • Remenyik E; Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Reznichenko N; Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine.
  • Stoevesandt J; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Ward ES; Centre for Cancer Immunology, University of Southampton, Southampton, UK.
  • Parys W; argenx, Ghent, Belgium.
  • de Haard H; argenx, Ghent, Belgium.
  • Dupuy P; argenx, Ghent, Belgium.
  • Verheesen P; argenx, Ghent, Belgium.
  • Schmidt E; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Joly P; Department of Dermatology, Rouen University Hospital, Rouen, France.
Br J Dermatol ; 186(3): 429-439, 2022 03.
Article em En | MEDLINE | ID: mdl-34608631

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article